RxDoctor Payments Data

Rocio Naranjo

Physician Assistant · Visalia, CANPI 1023345998

Payments from drug & device makers

$3,321in general payments, 2019–2025

Across 210 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Regeneron Healthcare Solutions, Inc.$720
  • AstraZeneca$420
  • Boehringer Ingelheim$358
  • Biocryst US Sales Co., LLC$212
  • Optinose US, Inc.$124
  • plus $427 from 8 others

What the payments were for

  • Food & beverage$3,28099%
  • Education$411%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,321 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$51,660
Medicare patients
113
Services billed
2,423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter68$42,600
Breo ElliptaFluticasone/Vilanterol25$11,525
Spiriva RespimatTiotropium Bromide11$7,721
Arnuity ElliptaFluticasone Furoate29$7,026
Advair HfaFluticasone Propion/Salmeterol15$5,741
SymbicortBudesonide/Formoterol Fumarate11$4,544
Azelastine Hcl76$2,724
Epinephrine11$2,566
Albuterol Sulfate HfaAlbuterol Sulfate59$1,814
Ipratropium Bromide31$1,130
Fluticasone Propionate94$1,130
Famotidine72$760
Levocetirizine Dihydrochloride42$724
Montelukast Sodium57$430
Triamcinolone Acetonide37$354

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$1,061$61,150122 claims
Boehringer IngelheimSpiriva Respimat$358$7,72111 claims
AstraZenecaSymbicort$420$4,54411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Visalia

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →